Latest Breaking News On - Xenia venture capital - Page 1 : comparemela.com

PolyPid's product for preventing surgical site infection failed to achieve its primary endpoint, although results for one subgroup of patients were more encouraging.

Dikla czaczkes akselbradYossi lazarovGary leibler shavitAdvanz pharmaCzaczkes akselbradChaim hurvitzRecanati glenrockDrug administrationFriendly angels clubVincent tchenguiz consensus business groupCzaczkes akselbrad creditXenia venture capitalMorris kahnAurum venturesGary leiblerShavit capital